Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 2a Clinical Trial to Assess the Safety and Efficacy of C3 Inhibitor AMY-101, in Adults With Gingivitis

Next Previous
Trial Profile

A Phase 2a Clinical Trial to Assess the Safety and Efficacy of C3 Inhibitor AMY-101, in Adults With Gingivitis

Status: Completed
Phase of Trial: Phase I/II

Latest Information Update: 27 Jan 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs AMY 101 (Primary)
  • Indications Gingivitis; Periodontitis
  • Focus Therapeutic Use
  • Sponsors Amyndas Pharmaceuticals

    • Most Recent Events

    • 01 Dec 2021 Primary endpoint (Change in mean gingival index (MGI)) has been met as per results published in the Journal of Clinical Investigation
    • 01 Dec 2021 Results published in the Journal of Clinical Investigation
    • 19 Mar 2021 According to an Amyndas Pharmaceuticals media release, company is planning to discussing these results with the U.S. FDA and other regulatory agencies, to design the best path forward, ideally through a multi-center phase 3 trial of AMY-101.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top